What's New

Tagraxofusp-erzs (Elzonris™)

Tagraxofusp-erzs (Elzonris™) is a chemotherapy used in the treatment of some types of blastic plasmacytoid dendritic cell neoplasm. 

Alpelisib (Piqray®)

Alpelisib (Piqray®) is a kinase inhibitor used in combination with fulvestrant in the treatment of metastatic or advanced breast cancer with a PIK3CA(phosphatidylinositol 3-kinase) mutation.

Blogs

OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.


Cancer Survivor’s Day/Month
by OncoLink Team
Jun 20, 2019


Fear: The Unwanted Passenger
by Carolyn Vachani, MSN, RN, AOCN
Jun 18, 2019


The Survival List
by Karen Arnold-Korzeniowski, BSN, RN
Jun 13, 2019


View all Blogs

Cancer Awareness

National Cancer Survivors Day

The first Sunday in June celebrates National Cancer Survivor’s Day. With over 13 million survivors in the US alone, there is a lot to celebrate! Learn more about cancer survivorship, watch the Navigating Life After Cancer webinar or create your own OncoLife Care Plan to celebrate your favorite survivor.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.